Leidos (NYSE: LDOS) insider files Rule 144 to sell 3000 shares
Rhea-AI Filing Summary
Leidos Holdings, Inc. has a notice to sell 3000 shares of its common stock under Rule 144. The planned sale is to be executed through Citigroup Global Markets, Inc. on the NYSE, with an aggregate market value of 544080.00, and an approximate sale date of 12/19/2025. The issuer reports 127855172 shares of common stock outstanding.
The 3000 shares were acquired on 12/19/2025 through a vested shares account from Leidos Holdings, Inc., with the nature of payment described as services rendered. The person on whose behalf the sale is made represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What insider share sale is disclosed for Leidos (LDOS) in this notice?
The notice covers a planned sale of 3000 shares of Leidos Holdings, Inc. common stock, to be sold through Citigroup Global Markets, Inc. on the NYSE.
What is the aggregate market value of the Leidos (LDOS) shares to be sold?
The 3000 Leidos Holdings, Inc. common shares to be sold have an aggregate market value of 544080.00 as stated in the notice.
When is the approximate sale date for the Leidos (LDOS) shares under this Rule 144 filing?
The approximate date of sale for the 3000 Leidos Holdings, Inc. common shares is listed as 12/19/2025.
How and when were the Leidos (LDOS) shares being sold acquired?
The 3000 common shares were acquired on 12/19/2025 via a Vested Shares Account from Leidos Holdings, Inc., with the nature of payment described as Services Rendered.
How many Leidos (LDOS) common shares are outstanding according to this notice?
The notice states that there are 127855172 shares of Leidos Holdings, Inc. common stock outstanding.
What representation does the seller make about Leidos (LDOS) in this Rule 144 notice?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.